Researchers found a strong association between monkey virus DNA and non-Hodgkin's lymphoma, suggesting the virus could play a role in its development. The study suggests that targeting the virus could help prevent its development and offers new therapeutic strategies.
Researchers at University of Wisconsin-Madison have discovered a potent way to shut down viruses by introducing harmless molecules that mimic the virus's growth machinery, outperforming traditional antiviral strategies in inhibiting viral growth and creating drug-resistant strains.
A study by Wildlife Conservation Society reveals that simultaneous Ebola outbreaks consist of multiple viral strains originating from different areas. The authors recommend establishing a monitoring network to look for dead and dying large animals as an early warning system to minimize damage to both people and wildlife.
The Ebola virus has unleashed several lethal epidemics in Central Africa, leading to haemorrhagic fever and high mortality rates. The virus is transmitted by direct contact with infected animals or their carcasses, resulting in a rapid decline in great ape populations.
Researchers have discovered a potential treatment for Ebola, showing a 33% survival rate among treated macaques. The study found that inhibiting blood coagulation pathways prolonged survival time and improved health outcomes.
A new drug, rNAPC2, has shown promising results in treating Ebola by slowing coagulopathy and death in primates. The treatment targets the disease process rather than replicating the virus, offering a potential breakthrough in combating the deadly disease.
Researchers at USAMRIID have developed Ebola virus-like particles (VLPs) that induce both cell-mediated and humoral immunity in mice, providing 100% protection against lethal challenge. The VLPs, resembling infectious viral particles without genetic material, offer a promising vaccine platform for Ebola and other viruses.
The first human trial of a DNA Ebola vaccine opened at the NIH Clinical Center in Bethesda. Twenty-seven volunteers will receive either the investigational vaccine or a placebo injection over two months and be followed for one year.
Rao's research aims to understand the mechanism of virus assembly, a crucial step in viral transmission and disease spread. By studying the brome mosaic virus, his lab hopes to develop new strategies for blocking virus assembly and preventing disease.
A live but weakened virus is being tested as a potential West Nile virus vaccine, with promising results showing high levels of protective antibodies in monkeys. The vaccine has been shown to be effective in preventing the disease-causing virus while triggering a strong immune response.
Scientists at NIAID and USAMRIID developed a prime-boost vaccine strategy that protects monkeys from Ebola infection. The boost alone shows promise in offering quick but weaker immune response.
Scientists create hybrid virus that can attach to lung cells' top surface, allowing healthy genes to enter and correct genetic defects associated with cystic fibrosis. The new approach increases production of viral particles, a crucial step towards preclinical studies.
A recent study warns of a dramatic decline in western equatorial Africa's great ape populations, with gorillas and chimpanzees facing nearly 60% decline since 1983. The research highlights the urgent need for aggressive investments in Ebola prevention, law enforcement, and protected area management to ensure their survival.
A study published in Nature reveals that wild chimpanzee and gorilla populations have declined by over 50% in the past few decades, with an estimated 80% decline expected within 30 years. The researchers attribute this to illegal hunting and Ebola outbreaks, highlighting the need for improved anti-poaching laws and Ebola research.
Researchers found that HIV patients develop strong antibody responses against the virus, but these antibodies fail to keep pace with the virus's constant mutation process. This study sheds light on the complex dynamics between the immune system and HIV, highlighting potential avenues for vaccine development.
Researchers discover protein from blue-green algae that inhibits both HIV and Ebola virus infections, potentially leading to new treatments. The protein works by binding to the outside of the viruses and blocking them from entering cells.
Scientists at Imperial College London have discovered a unique method of viral transmission by the HTLV-1 leukaemia virus. The virus infects cells and transfers itself to other cells without releasing particles, evading the immune system and paving the way for potential new treatments.
Researchers found a biochemical structure similarity between the Ebola virus outer protein shell and retroviruses carried by birds, suggesting possible bird transmission. This discovery raises health concerns for humans and encourages officials to be vigilant.
Researchers at Purdue University have simplified the outer shell of the Ebola virus, making it easier to produce in a lab and delivering genes to defective cells. This breakthrough could lead to treatments for diseases like cystic fibrosis and lung cancer.
A team of scientists has developed a laboratory system to study the virus in its latent stage, discovering genes that may give it stealth capabilities. This could lead to the development of new drugs to clear the virus from infected individuals.
Researchers at Temple University have discovered a possible link between the common human virus JC virus and colon cancer. The study found that the viral genome and proteins were present in malignant epithelial tumors in the large intestine, which may play a role in tumor development.
Scientists found that herpes virus uses regulators of complement activation (RCA) to evade the immune system. The study reveals that complement plays a crucial role in controlling persistent and latent infection, contradicting previous assumptions.
Hemorrhagic fever viruses, such as Ebola and Marburg, pose significant threats due to their high mortality rates and lack of effective treatments. The report recommends improving diagnostic capacity, developing rapid tests, and researching new antiviral medications to counter these threats.
Researchers demonstrate that Ebola and Marburg viruses rely on lipid rafts in the cell membrane to gain entry and assemble. This finding opens up potential therapeutic avenues against these deadly pathogens.
Researchers mapped areas of Africa at risk for RVF outbreaks, identifying conditions necessary for breeding mosquitoes that transmit the virus. Satellite data also suggested a link between dry to wet changes in tropical regions and Ebola outbreaks.
The study reveals how the T4 virus binds to host cells, punctures the cell wall, and injects its genetic blueprint into the cell. The research provides detailed information on the virus structure and mechanisms used by one virus often resemble those of other viruses, including those that infect humans.
Yale scientists have successfully immunized mice against West Nile virus, providing a promising lead for developing a vaccine for humans. The vaccine was developed using a protein found in the virus and showed complete protection against the disease.
Researchers found that a minor change in the arrangement of molecules can turn a relatively benign flu virus into a deadly one. The study used mice to show that even a small amount of the virulent form of the virus was enough to cause fatal infections, highlighting the potential for animal-to-human transmission.
Gladstone researchers identified a key protein on cells that can be targeted to block Ebola and Marburg virus entry. This finding offers new hope for developing treatments against these deadly viruses.
New research suggests that macrophages are an underappreciated reservoir of virus in HIV infection. Macrophages continue to produce large amounts of an HIV-like virus even after CD4+ T cells are depleted, providing new insight on how the virus survives. This discovery may lead to new strategies for eliminating the virus from the body.
Researchers at the University of Pennsylvania have discovered a key protein, VP40, crucial for Ebola's replication cycle. This finding holds promise for developing novel antiviral drugs to stop the spread of the deadly disease.
A team of researchers at NIH has developed a novel vaccine that prevents Ebola virus infection in monkeys, offering a promising new approach to protecting humans. The vaccine induces strong anti-Ebola immune responses and protects against lethal doses of the virus.
Scientists have identified a portion of the HIV genome that remains unaffected by mutations, providing a potential therapeutic target for preventing viral spread. By blocking this site, researchers believe they can inhibit viral replication and develop a new treatment approach.
Researchers have discovered a potentially promising approach to attack the AIDS virus, opening new vaccine directions. The study found that infected individuals make immune responses that the virus cannot tolerate, and that these responses could be mimicked in an HIV vaccine.
Researchers have identified a viral protein responsible for Ebola-induced internal bleeding. The discovery could lead to the development of targeted antiviral treatments and vaccines to prevent the disease. By understanding how the virus attaches to and enters cells, scientists can design more effective countermeasures.
Researchers at Purdue University will study the three-dimensional structure of several types of viruses, including yellow fever and hepatitis C viruses, using a combination of X-ray crystallography and molecular biology techniques. The goal is to develop drugs that prevent infection by similar viral pathogens.
Researchers at Purdue University have identified a protein segment crucial for the infection of cells by retroviruses and other viruses. By replacing just one amino acid in this region, they were able to eliminate fusion between the virus and its host cell. This discovery may lead to novel treatments to block the entry of these viruses.
Scientists discovered a common viral harpoon protein structure among measles, mumps and respiratory syncytial viruses. This finding suggests that these viruses may be related to HIV, influenza and Ebola viruses, potentially leading to the development of new drugs.
Australian scientists have discovered key facts about the Hendra disease, a mysterious virus that infects horses, cats, guinea pigs, and fruit bats. Research shows the virus can be transmitted through contaminated food and cat urine, and is often deadly, even if not highly contagious.
Researchers at Jefferson Medical College have found a way to inhibit the hepatitis B virus by blocking its envelope creation, resulting in a dramatic drop in viral levels. The discovery may provide new leads for treating chronic HBV and HCV infections in humans.